These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 jen. The technology gains life-saving medical insights by analysing human excrement. Konpayi an te depoze yon seri de twa patant ki kouvri eleman nan Capteur twalèt medikal li yo.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Ewòp, Japon ak Lachin.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Teknoloji OutSense a ka idantifye sous la nan san nan aparèy la gastwoentestinal.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Dapre CEO OutSense Yfat Scialom, who predicts that “ak eksplozyon an nan medikaman dijital, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, maladi enflamatwa entesten ak enfeksyon nan aparèy urin.

Its solution consists of a multispectral optical sensor, yon sous limyè ak yon aparèy tès depistaj otonòm ki gen ladann yon koneksyon WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Enfòmasyon yo jwenn nan echantiyon san, konbine avèk analiz adisyonèl sou tan ki soti nan senyen rive nan eskresyon, bay detay sou patoloji senyen an. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense te anonse ke CommuniCare, yon gwo konpayi swen sante ki gen plis pase 90 healthcare facilities in the US, pral kòmanse pilote teknoloji li ane sa a. Anplis pilòt sa a, OutSense also plans to conduct clinical trials in Israel and Japan.

Vizite plis nouvèl nan Viga.cc Nouvèl